🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT07634757
Starting soon Observational

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents

NCT07634757 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-06-10

Condition(s) studied

Nursing Home CareHospitalisation Prevention

Investigational drug(s) / intervention(s)

Mobile Geriatric Unit (MGU)

Mobile Geriatric Unit (MGU): The MGU is a mobile diagnostic unit providing on-site diagnostics in nursing homes. It includes a 32-slice (64 slice reconstruction) whole body CT scanner, digital X-ray, portable ultrasound, ECG, EEG, and point-of-care laboratory diagnostics. A physician and radiology technician perform diagnostics on-site. Results are transmitted via telemedicine to hospital specialists and communicated to the general practitioner for treatment decisions within 48 hours.

Study summary

This prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase during which the MGU is implemented. The MGU provides advanced on-site diagnostics and telemedicine-supported specialist consultation within nursing homes.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Residents of participating nursing homes * Informed consent from participant or legal representative Exclusion Criteria: * Acute life-threatening conditions requiring immediate hospitalisation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nursing Homes in Saarland Homburg Saarland

More Universität des Saarlandes trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07634757 on ClinicalTrials.gov ↗ ← All trials in Germany